If you need additional assistance or information regarding the company, contact the Media Relations Department at Alexion's corporate offices at (203) 272-2596, or contact us by email.

Current Press Releases

10/25/2007	Alexion Reports Third Quarter 2007 Results
09/04/2007	Alexion To Present At Bear Stearns Healthcare Conference
08/20/2007	PNH Patients Treated with Soliris™ Experienced Dramatic Reduction in Blood Clots During Clinical Trials
07/25/2007	Alexion Reports Second Quarter 2007 Results
07/12/2007	Alexion Pharmaceuticals Invites You to Participate in its Second Quarter Results Conference Call and Web Cast
06/22/2007	ALEXION’S SOLIRIS™ GRANTED MARKETING APPROVAL IN EUROPE FOR TREATMENT OF ALL PATIENTS WITH PNH
06/13/2007	Alexion To Present At The William Blair 27th Annual Growth Stock Conference
06/11/2007	STUDIES SHOW EFFICACY AND SAFETY OF ALEXION’S SOLIRIS™
06/05/2007	Alexion To Present At The Goldman Sachs 28th Annual Global Healthcare Conference
06/04/2007	SOLIRIS™ EFFECTIVE IN PNH PATIENTS WITH HISTORY OF APLASTIC ANEMIA AND MYELODYSPLASTIC SYNDROMES
> >	Showing 1 - 10 of 58

Alexion provides the following press releases and other information as an archival service, for historic record only. Some of our releases may not be included in this archive. These releases and other material contain information that may now be out of date, and no longer true. Alexion makes no commitment, and accepts no duty, to update any information contained in these releases and other material. Information contained in material originally published by parties other than Alexion is provided only as a convenience, and Alexion makes no representation or warranty regarding its accuracy or completeness.